Private Equity
Orladeyo is the first oral, once-daily plasma kallikrein inhibitor indicated for the treatment of hereditary angioedema.
1 min read · 27 June 2025
NDA is a water infrastructure group in the Nordics region.
1 min read · 27 June 2025
The garments specialize in post-surgical recovery solutions.
1 min read · 26 June 2025
The transaction is expected to close in July 2025.
1 min read · 26 June 2025
Scott Burdick serves as CEO of Northstar.
1 min read · 26 June 2025
Avante Capital Partners and Brightwood Capital Advisors provided debt and equity financing for the transaction.
1 min read · 26 June 2025
The investment will be used to accelerate growth through new studio development and strategic acquisitions across the Southeastern and Mid-Atlantic US.
1 min read · 26 June 2025
AtkinsRéalis is a Canadian engineering services and nuclear business.
2 min read · 26 June 2025
The fundraising brings the company's total funding to $110 million.
1 min read · 26 June 2025
The transaction is expected to be completed in the fourth quarter of 2025.
1 min read · 26 June 2025